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Lithium clearance during the paradoxical natriuresis of
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Lithium clearance during the paradoxical natriuresis of hypotonic
expansion in man. Tubular sodium handling in humans undergoing
iypotonic expansion due to the administration of antidiuretic hormone
was studied using the clearance of lithium as an index of distal filtrate
and sodium delivery. Clearance studies were performed in the morning
in eight normal subjects before and on the fourth day of intranasal
1-desamino-8-D-arginine vasopressin (dDAVP) administration. Fluid
intake was kept constant at 25 mI/kg body weight. After dDAVP body
weight increased (2.5 0.4 kg), plasma sodium fell (from 143 Ito 128
5 mmol/liter) and a progressive natnuresis developed. Sodium
balance remained negative up to the second clearance study, when the
cumulative sodium loss amounted to 148 96 mmol. Plasma renin
activity fell significantly, but plasma aldosterone did not. Inulin clear-
ance rose from 110 14 to 135 23 mI/mm and lithium clearance from
30.9 7.6 to 48.9 15.1 mI/mm. Fractional reabsorption of uric acid,
phosphate and calcium decreased. Together these changes suggest that
the negative sodium balance in hypotonic expansion with dDAVP
results from increased filtered sodium load, decreased fractional reab-
sorption in the proximal tubules, and increased distal delivery. Esti-
mated fractional reabsorption in the distal nephron remained unaltered.
The plasma concentration of lithium, of which 10.8 mmol was ingested
n the eve of the clearance studies, was not lower during the dDAVP-
clearance study. This indicates that the tubular adaptations mentioned
are present intermittently, in particular during daytime.
during maximal water diuresis, can evidently not be applied in
this situation, has undoubtedly contributed to this hiatus.
Several years ago [7] and again more recently [8, 9], lithium
has been advanced as a quantitative marker of proximal tubular
sodium handling, and lithium clearance has been used as a
method to analyze tubular sodium handling in recent studies in
man [10, 11] and dog [12]. As this method can also be used
during ADH-induced hypotonic expansion, we studied renal
lithium handling in healthy subjects before and during the
natriuretic phase of hypotonic expansion induced by adminis-




Studies were performed in eight healthy subjects (6 males, 2
females, aged 25 4 yr, body weight 65.0 5.9 kg). The study
protocol had been approved by the Hospital Committee for
Human Research and informed consent was obtained from all
subjects.
Study protocol
When hypotonic expansion is induced in the presence of
increased plasma levels of antidiuretic hormone (ADH), a
transient natriuresis is observed [1—4]. This natriuresis is prob-
ably a direct effect of volume expansion as it occurs only when
sufficient water is supplied to induce a positive water balance
[3, 5, 6]. The changes in renal sodium handling involved have
not been completely elucidated, but it is likely that adaptations
which normally accompany extracellular volume expansion will
take place: an increase in glomerular filtration rate and depres-
sion of fractional sodium reabsorption at various nephron
levels.
Systematic studies analyzing renal hemodynamics and seg-
mental tubular sodium handling during chronic, ADH-induced
hypotonic expansion in man have not been performed. The fact
that the most widely used method to study segmental tubular
sodium handling in man, that is, the clearance study performed
The subjects ingested a diet containing 120 mmol sodium and
100 mmol potassium per day. Fluid intake was standardized to
25 mI/kg body weight in addition to water present in solid foods.
The diet was continued throughout the study. The first clear-
ance study was performed on the fourth day of the diet. The
next day intranasal administration of dDAVP (Minrin') was
started in a dose of 20 sg three times a day. dDAVP was chosen
because of its lack of pressor effects [13], long duration of
action and ease of administration. The second clearance study
was performed on the fourth day of dDAVP administration.
On clearance days blood specimens were drawn to measure
supine hematocrit, total protein, plasma renin activity (PRA)
and plasma aldosterone concentration.
The study was performed on an out—patient basis. At daily
visits body weight and supine blood pressure were measured,
and a blood specimen was obtained to check the degree of
plasma hypotonicity. Twenty—four hour urinary collections
were made daily.
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Clearance studies
Lithium carbonate (400 mg, 10.8 mmol lithium) was taken
between 10 and 12 p.m. on days preceding clearance studies.
376
Lithium clearance and hvpotonic expansion in man 377
These were performed in the morning hours, the subjects
remaining supine. Breakfast (containing 30 mmol of sodium and
250 ml of fluid) was taken between 7:30 and 8:00 a.m. The last
dose of dDAVP was given at 8:00 a.m. on the day of the second
clearance study. At 9:00 a.m. intravenous catheters were
placed in an antecubital vein on both arms. A prime dose (36 to
40 ml) of a solution containing 10% inulin (polyfructosan,
InutestR) and 2.5% para amino hippuric acid (PAH) was admin-
istered in 10 minutes, followed by a continuous slow (18 to 22
mi/hour) infusion. The actual clearance study was started after
an equilibration period of one hour. To enhance urine flow, a
water load of 10 mI/kg body weight was administered in this
period prior to the first clearance study. However, no water
load was given before the second study, since it was expected
that this load would be retained after administration of dDAVP,
causing acute volume expansion. After the equilibration period,
three urine collections of 20 to 30 minutes each were obtained
by spontaneous voiding. During the second clearance study,
collection periods sometimes were extended to 40 minutes due
to low urine flows. Blood samples were drawn at the midpoint
of collection periods. Clearances were calculated using the
standard formula [141. For the calculation of calcium clearance,
uitraflltrable calcium was estimated to be 60% of total plasma
calcium.
Segmental tubular sodium handling derived from the lithium
clearance
Based on the assumptions, that (a) lithium is reabsorbed in
the proximal tubules in parallel with sodium and water and (b)
lithium is neither reabsorbed nor secreted beyond the proximal
tubules [8], the following calculations regarding segmental
tubular sodium handling were made:
1) FLNa = GFR X
2) DDNa CL X PNaIl000
3) APRia = FLNa — DDNa
4) ADRNa = DDNa - UNa V
5) FPRNa (APRNa/FLNa) >< 100 %





In these formulas FLNa is the filtered sodium load, DDNa the
distal sodium delivery, APRNS the absolute proximal sodium
reabsorption, ADRNa the absolute distal sodium reabsorption,
FPRNa the fractional proximal sodium reabsorption, and FDRNa
the fractional distal sodium reabsorption.
Analytical methods
Sodium and potassium concentrations were determined using
an Instrumentation Laboratory Autocal 743 flame photometer
(Lexington, Massachusetts, USA). Chloride, calcium, phos-
phate, urea, creatinine, uric acid and total protein concentra-
tions were measured on a Technicon RA-l000 autoanalyzer
(Technicon Instruments mc, Tarrytown, New York, USA).
Osmolality was measured using an Advanced Osmometer.
Inulin was hydrolyzed to fructose and determined photometri-
cally with indolacetic acid [151 and PAH was determined
photometrically by a chromogenic aldehyde reaction [16]. PRA
and plasma aldosterone were measured by radioimmunoassay
[17]. Concentrations of lithium in urine and plasma samples
were measured using a Perkin Elmer 3030 Atomic Absorption
Spectrophotometer (Perkin Elmer, Norwalk, Connecticut,
USA).
Statistical analysis
Data are expressed as the mean standard deviation. Paired
observations were compaired using Student's t-test for paired
samples. Analysis of variance for repeated measures was used
for variables measured more than twice.
Results
Body weight, blood pressure and urinary water and
electrolyte excretion
Water retention led to an increase in body weight of 2.5 0.4
kg (P < 0.001) (Fig. 1). Daily urine output fell from 1776 372
mI/day to 914 163 mI/day on the first day of dDAVP
administration. Urine osmolality increased from 592 225 to
908 117 mOsm/kg. Both variables tended to return to baseline
values the day before the second clearance study (1399 416
mi/day and 611 171 mOsm/kg, respectively). Daily sodium
excretion rose progressively from 113 17 mmol/day to 194
50 mmoi/day on the day preceding the second clearance study.
At this stage, cumulative sodium loss averaged 148 96 mmoi.
Urinary potassium excretion fell from 75 11 to 59 13
mmol/day on the day before the second clearance study (P <
0.05). Mean arterial pressure did not change during the study.
Changes in blood composition and hormonal parameters
Plasma chloride, urea, creatinine, total calcium, inorganic
phosphate and total protein concentration and plasma osmolal-
ity all fell significantly (Table 1). Although not expected in case
of a pure water expansion, hematocrit also decreased. The fall
in plasma uric acid concentration was particularly striking (Fig.
1). PRA was suppressed, but this was not accompanied by a fail
in plasma aldosterone concentration, which even increased in
five cases.
Clearance data
On the fourth day of expansion inulin and PAH clearance had
increased by 24 23 and 41 24%, respectively (Table 2).
Lithium clearance increased in all subjects (Fig. 2). Stable
plasma lithium concentrations were obtained, falling by no
more than 6 3 and 8 5% during the first and second
clearance study, respectively. The concentrations at the begin-
ning of both clearance studies (0.143 0.021 and 0.141 0.025
mmol/liter, respectively) did not differ. These values are well
below the level of 0.4 mmol/liter, above which renal sodium or
water handling may be affected [18]. The clearances of uric
acid, phosphate and calcium all increased in parallel with that of
lithium. As these increases were more pronounced than the
increase in inulin clearance, fractional reabsorption of all these
substances fell significantly. Mean urine flow during the control
study was 7.1 5.5 mI/mm with a mean urine osmolality of 243
170 mOsm/kg. In the expanded state, the values for these
variables were 2.6 1.0 mI/mm and 544 179 mOsm/kg,
respectively.
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Sodium mmol/liter 143 1 128 5 <0.001
Potassium mmol/liter 4.2 0.3 4.1 0.3 NS
Chloride mmol/liter 105 3 96 3 <0.005
Bicarbonate mmol/liter 24 2 25 2 NS
Uric acid mmol/ljter 0.35 0.05 0.22 0.06 <0.001
Phosphate mmol/liter 1.15 0.14 0.96 0.13 <0.005
Total calcium mmol/liter 2.47 0.07 2.28 0.12 <0.001
Urea ,nmollliter 5.7 0.4 3.9 0.8 <0.001
Creatinine imo1/1iler 91 13 79 7 <0.05
Osmolality mOsm/kg 284 3 257 11 <0.001
Total protein glliter 71 5 64 5 <0.005
Hematocrit % 43 3 39 3 <0.001
PRAfmoIA,/l.s 295 169 78 41 <0.05
PA pmo/Iliter 177 47 223 125 NS
Segmental tubular sodium handling
Despite the fall in plasma sodium concentration, the rise in
glomerular filtration rate resulted in an increased filtered so-
dium load in seven cases (Table 3). This increase however was
not statistically significant due to a relatively large fall in one
subject. In each case fractional lithium reabsorption fell and by
inference fractional proximal reabsorption decreased. Absolute
sodium delivery to the distal nephron increased markedly but
was almost matched by a rise in absolute reabsorption.
Fractional distal reabsorption did not change significantly.
Net sodium excretion during the study in the expanded state
was elevated in comparison to the pre-expansion study: 348
126 versus 221 83 mol/min (P < 0,005). During both
clearance studies sodium excretion rate was higher than ex-
pected from 24-hour urine output; this phenomenon must
probably be attributed to the diurnal variation in sodium excre-
tion, which may peak in the morning hours [19, 201.
Discussion
This study confirms the observation [1—3, 21, 22j that a
natriuresis ensues during the first days of vasopressin—induced
Control Expansion P
GFR mI/mm 110 14 135 23 <0.001
ERPF mI/mm 629 103 880 191 <0.01
FF % 17.7 1.9 15.7 2.8 NS
Clithium mI/mm 30.9 7.6 48.9 15.1 <0.01
acid mi/mm 9.2 2.7 19.1 4.9 <0.001
Cphosphate mi/mm 9.1 4.8 15.5 5.7 <0.001
Cci,rn mi/mm 4.3 2.3 8.2 4.2 <0.005
FRjIthU, % 72.0 6.1 64.6 5.8 <0.01
FRuric acid 915 3.2 86.0 1.4 <0.001
FRphc,uphate % 91.5 4.7 88.5 4.1 <0.05
FRcaicium % 96.2 1.5 94.1 2.3 <0.01
hypotonic overhydration. Clearance studies showed a rise in
glomerular filtration rate, filtered sodium load and fractional
clearances of lithium, uric acid, phosphate and calcium, indi-
cating that this natriuresis is the combined effect of an increased
filtered sodium load and reduced fractional reabsorption of
sodium chloride in the proximal nephron.
Glomerular filtration rate increased to such an extent that,
despite the fall in plasma sodium concentration, filtered sodium
load increased in all but one subject, The rise in glomerular
filtration rate was of a similar magnitude as observed in normal
subjects volume expanded by an extremely high sodium intake
f23] or mineralocorticoid administration [241. This forms indi-
rect evidence of significant extracellular volume expansion
during chronic ADH excess. In agreement with this notion
effective renal plasma flow increased as well.
Fractional and absolute lithium clearance increased in all
subjects during expansion. When lithium clearance was used to
quantify sodium reabsorption in the proximal tubule, absolute
sodium reabsorption in this segment appeared unaltered despite
the increase in filtered load. Fractional proximal reabsorption
was therefore lower, indicating resetting of glomerulo-tubular
balance as expected during volume expansion. This finding
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Fig. 1. Changes in urinary water, electrolyte and uric
acid excretion, urine osmolality and plasma sodium,
potassium and uric acid concentration during dDAVP-
induced hypotonic expansion in eight normal subjects.
Data are expressed as mean SEM. Asterisks indicate
statistically significant (P < 0.05) differences from the
values obtained in the control period (days 2 and 3)
analyzed by one—way analysis of variance for repeated
measures.
Table 2. Clearance data
Abbreviations are: PRA, plasma renin activity; PA, plasma aldoster-
one; NS, not significant.
Abbreviations are: GFR, glomerular filtration rate; ERPF, effective
renal plasma flow; FF, filtration fraction; C, clearance; FR, fractional
reabsorption; NS, not significant.
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in dogs in which fractional proximal reabsorption fell by ap-
proximately 6% during ADH-induced expansion [251.
Absolute and fractional uric acid clearance rose consistently
and marked hypouricemia developed. These findings confirm
previous observations in patients with inappropriate ADH
secretion [26, 27] and normal subjects with experimental ADH
expansion [26]. Uric acid handling is probably restricted to the
proximal nephron, involving a bidirectional transport mecha-
nism. Net reabsorption is presumed to be linked to proximal
sodium reabsorption [28]. Two additional alleged markers of
proximal tubular sodium reabsorption, phosphate and calcium
[14], behaved as lithium and uric acid, in that both absolute and
fractional clearance increased during expansion. The parallel
changes in renal handling of all these substances strongly
support the notion that fractional proximal sodium reabsorption
is depressed during hypotonic expansion.
It is noteworthy that the elevated distal sodium delivery,
calculated with the lithium—method on the fourth day of ADH
expansion, was practically matched by an increased distal
reabsorption (Table 3). Although the subjects were still in a
Control Expansion P
Filtered load mmollmin 15.7 2.1 17.3 1.3 0.11
APRNa mmol/min 11.1 1.6 11.0 1.3 NS
Distal delivery mmollmin 4.6 0.7 6.4 1.9 <0.05
ADRNa mmollmin 4.4 0.7 6.0 1.8 <0.05
FPRN % 72.0 6.1 64.6 5.8 <0.01
FDRN % 95.1 2.1 94.5 1.4 NS
FENa % 1.4 0.5 2.0 0.5 <0.05
negative sodium balance at the time of this study (Fig. 1), it can
be presumed that such a rise in distal sodium reabsorption plays
a primary role in the eventual escape from the natriuretic effect
of ADH-expansion. The persistence of hypouricemia in patients
with ADH excess (26, 27] indeed suggests that this escape takes
place somewhere in the distal nephron, but the mediation is not
clear.
The mean plasma lithium concentrations during the clearance
studies were not different before and after dDAVP expansion.
Since lithium dosage and time of intake (between 10 and 12 p.m.
on the eve of the clearance studies) were the same, this suggests
unaltered lithium clearance during the night preceding the
clearance studies, in clear contrast to the enhanced lithium
clearance found during dDAVP in the morning. It may be that
during chronic hypotonic expansion with ADI-I analogues the
enhancement of lithium excretion, or rather the suppression of
proximal tubular sodium reabsorption and negative sodium
balance are present only intermittently, that is, during daytime
as part of the circadian rhythm, or triggered by positional
changes, food or fluid intake. That the circadian variation in
sodium chloride excretion is indeed maintained during hypo-
tonic expansion appetrs from the data presented by Wrong [4],
and corresponds with our observation that during both clear-
ance studies the sodium excretion rates were much higher than
the 24 hour excretion rates. A striking feature was that the urine
flow during the second clearance study, that is, two to three
hours after administration of a long—acting ADH analogue, was
so high as well. This attenuated dDAVP effect is probably the
expression of escape from its hydro-osmotic effect. This phe-
nomenon, also apparent from the decrease in urine osmolality
after an initial rise (Fig. I), occurs some days after the induction
of experimental ADH expansion [6, 7.91.
The rise in glomerular filtration and suppression of proximal
tubular reabsorption found in the clearance studies is in agree-
ment with an increase in extracellular fluid. However, the
actual expansion was probably modest. From the average pre-
and post-expansion plasma sodium concentrations (143 and 128
mmol/liter, respectively) and the cumulative sodium balance
(—148 mmol), it can be estimated that expansion of this com-
partment amounted to 4 to 5% at most. However, the large
interindividual differences in cumulative sodium balance make
any general conclusion about changes in extracellular fluid
volume hazardous. Moreover, cells exposed to chronic hypo-
tonicity probably adapt to this situation by reducing their
Table 3. Segmental tubular sodium handling derived from lithium
clearance
Abbreviations are: APRN, absolute proximal sodium reabsorption;
ADRNa, absolute distal sodium reabsorption; FPRNa, fractional proxi-
mal sodium reabsorption; FDRN, fractional distal sodium reabsorp-














Fig. 2. Individual lithium clearances (mi/mm) in eight normal subjects
before and during dDA VP-induced hypotonic expansion.
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osmotic content [30], which adds further uncertainty to specu-
lations about the degree of extracellular expansion. Therefore,
in the absence of direct measurements of body fluid volumes, it
remains difficult to judge whether the observed changes in renal
function and renin suppression can be adequately explained by
extracellular volume expansion. Few direct measurements have
been reported, with conflicting results [26, 31—341. But even if
the extracellular expansion was limited, the observed fall in
plasma protein concentration and hematocrit indicate a consid-
erable rise in plasma volume (—'15%) which may have contrib-
uted to the changes in renal function, This suggests a preferen-
tial increase in the intravascular volume as suggested earlier by
Bie, Munksdorf and Warberg [35]. In agreement is the obser-
vation by Drew et al [36] of a fall in hematocrit and plasma renin
activity and a rise in creatinine clearance in vasopressin—treated
normal subjects in whom water retention was prevented.
The quantitative analysis of segmental tubular sodium han-
dling was based on the assumption that lithium is a quantitative
marker of proximal tubular sodium reabsorption. Evidence
supporting the notion that lithium is reabsorbed in the proximal
tubules pan passu with sodium has been presented in micro-
puncture and clearance studies in rats [9, 37—39] and clearance
studies in humans [40]. However, as some distal lithium reab-
sorption, such as in Henle's loop, can not be excluded [37, 41],
our quantitative analysis has to be interpreted with some
caution. Nevertheless, since the bulk of the filtered lithium is
reabsorbed in the proximal tubules [8], the substantial rise in
fractional lithium excretion would still indicate suppression of
proximal sodium reabsorption during dDA VP-induced volume
expansion.
In summary, hypotonic expansion during dDAVP adminis-
tration induces a negative sodium balance characterized by
increased glomerular filtration and suppressed proximal sodium
reabsorption. Absolute distal tubular sodium reabsorption in-
creased, which may contribute to the eventual escape from the
natriuretic effect of hypotonic expansion. These changes may
be present intermittently, especially during daytime, as part of
the maintained circadian variation in solute excretion.
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